CABA news

Caring Brands, Inc. voted to amend its certificate to increase the authorized Series A Convertible Preferred Stock from 4,000 to 4,500 shares. This capital adjustment grants the company increased financial flexibility to pursue strategic initiatives or future funding needs.

Cabaletta Bio modified its capital structure to authorize 593.6M voting common shares, 6.4M non-voting common shares, and 10M preferred shares. The amendment enables the company to issue non-voting equity while preserving voting control for existing shareholders.

Cabaletta announced encouraging Phase 1/2 clinical data for rese-cel across dermatomyositis, systemic sclerosis, and lupus, with 83% of dermatomyositis patients meeting registrational endpoints and maintaining responses off immunomodulators. The company plans to initiate systemic sclerosis registrat…